Egyptian Journal of Medical Human Genetics

Table 5 Disease-free survival of the studied AML patients

From: Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia

Groups	Total N	N of events	PFS (months)		95% CI		PFS at (%) months			Log Rank Test
Groups	Total N	N of events	Median	SE	Lower	Upper	3 months (%)	6 months (%)	12 months (%)	X²	P value
P1P1 and P1P2	18	2	19.500	2.756	14.099	24.901	75.00	75.00	75.00	0.345	0.557
P2P2	22	6	17.513	2.123	13.351	21.674	90.00	78.80	59.10

DFS disease-free survival, SE standard error, N number

Back to article page